Pauline is a healthcare executive with more than 25 years’ experience within the life sciences sector. Pauline is a trusted and proven facilitator and has chaired numerous internal and external meetings with diverse stakeholders. She is active on social media and can highlight and encourage interest in key topic areas, such as consumer involvement in the life sciences sector. Pauline's insights have been gained from working in leadership roles both in industry (eg, Merck, AstraZeneca, Sanofi, Eli Lilly, MSD) and as a consultant (eg, Envision Pharma Group, Blackdot, Swordfish). Her experience spans across several different corporate functions and she has worked extensively across the Asia Pacific region. In each of her roles, her passion for excellence and her authentic leadership style have resulted in a positive team-based culture and tangible business transformations. Pauline has a Biological Sciences (Hons} degree from Birmingham University and is a member of the Australian Institute of Company Directors

A medically qualified life science executive, with 28 years strategic and operational leadership roles in the UK, Asia Pacific and ANZ regions. Jamshed has extensive experience in Women’s Health, Immunology, Oncology, Rare Diseases and the Neurology/MS disease arenas, with many innovative and successful biotechnology medicines launches, redefining standards of care for patients and healthcare delivery. I was lucky to have been involved in the value creation and sale of iNova Pharmaceuticals, and helped to fund an innovative digital health and patient safety solution, which has grown from a start up in Australia, to now being a global company too. The diversity gained by having worked for British, American, Australian, French and Danish healthcare companies including another innovative life science and technology company 3M, has been invaluable in experiencing different opinions and cultures. I am honoured to be at a German global science and technology company Merck, that is steeped in history and still transforming many aspects of people’s lives in healthcare, life sciences and digital health.

Paul graduated in Medicine from the University of Cambridge in 1988 and from Imperial College School of Medicine at St Mary’s in 1991. He worked in a variety of clinical and academic positions in the UK specialising in infectious diseases and virology, gaining Membership of the Royal College of Physicians in 1996. Subsequently, he completed an MBA from London Business School in 2003, and has been elected a Fellow of the Faculty of Pharmaceutical Medicine in the UK. He is also a Graduate of the Australian Institute of Company Directors. Paul joined the pharmaceutical industry with Bristol-Myers Squibb UK in 1997 and has held positions of increasing scope and responsibility in the UK, across Europe, Middle East & Africa, in Australia, across Asia-Pacific, and for Global, including the role of Executive Director, Global Medical Affairs at BMS in Princeton, NJ and Senior Director (and interim VP), Medical Affairs for Asia-Pacific at Janssen/J&J. In 2015 Paul joined Gilead Sciences, where he has been Senior Medical Director for Gilead ANZ, interim General Manager ANZ in 2019, Medical Affairs lead for Covid-19/remdesivir for ANZ, Nordics, BeNeLux, Israel, Austria and Switzerland in 2020, and most recently completed a developmental secondment as Senior Director, Commercial Operations. He is also a Member of Industry Advisory Committee of the Doherty PhD Program.

Professor Karen Woolley is honoured to be a Life Member of ARCS and served ARCS as a Director and Chair of the Board. As a bereaved parent, clinical trial participant, and caregiver to immediate family members with acute and chronic conditions, Karen’s lived experience has motivated her to work with patients - as partners - in her medical communications career. With patient leaders in the Asia Pacific, European, and North American regions and her medical communication colleagues, she has conducted, presented, and published award-winning research on the ethical and effective involvement of patients in publications. This research has led to practical outcomes with the co-creation of free, evidence-based, online resources for plain language summaries of publications (www.envisionthepatient.com/plstoolkit) and for patient authorship www.patientauthorship.com/). Karen is a Professor at two universities, she has served on the Boards of government hospital and healthcare services (serving 400,000 patients) and not-for-profit research and medical communication associations, she has authored the Good Publication Practice 3 guidelines, prepared Position Statements on the ethical use of professional medical writers for European, American, and international not-for-profit associations, and served on the Editorial Board for an international research integrity journal. To renew her energy, she surfs, runs, cycles, and stairclimbs with (mostly) willing family and friends.